# Differentiated Therapeutics

**Canonical:** https://apis.io/providers/differentiated-therapeutics/  
**Website:** https://www.dxtherapeutics.com  
**APIs profiled:** 0

Differentiated Therapeutics (dx/tx) is a protein degradation company focused on discovering and developing transformative therapies using targeted protein degradation. It operates an end‑to‑end discovery engine combining biophysics, chemoproteomics, molecular simulation, AI and automation to map and design novel protein degraders, aiming to eliminate genetically defined disease drivers.

## Kin Score — 4.7 / 100 (minimal)

Scored 2026-10-31 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 5.3 |
| Developer Ergonomics | 2.4 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 5.5 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Differentiated Therapeutics Domain Security** — TLSv1.3 · HSTS · DNSSEC · DMARC

## Tags

Therapeutics, Protein Degradation, Drug Discovery, Artificial Intelligence, Biophysics, chemoproteomics, Molecular Simulation

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/differentiated-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.